|
|
| Home | Stock Market Blogs | Financial Tools | Sign Up Free | |
| PhytoMedical Technologies, Inc. | |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhytoMedical Technologies, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PYTO | Last: $0.03 ($+0.001) | Volume: 69,268 | Last Trade: 8/5/2010 5:20:17 PM | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Today
Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhytoMedical Technologies, Inc. Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhytoMedical Technologies together with its subsidiaries, is a pharmaceutical company focused on research, development and commercialization of pharmaceutical products. Co. is working to isolate potentially active pharmacological elements in its first plant derived compound, BDC-03, for the treatment of cachexia, which is characterized by weight loss in fatty tissue, muscle tissue and bone. In addition, Co. is synthesizing the active components of several polyphenolic compounds found in cinnamon bark and identifying a Type 2 Diabetes candidate for an Investigational New Drug application with the FDA. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhytoMedical Technologies, Inc. News & Press Releases | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
PhytoMedical Advances Research of Patented Anti-Cancer Compound ... PR-Inside.com (Pressemitteilung): PhytoMedical Advances Research of Patented Anti-Cancer Compound ... , Austria - Mar 18, 2008 PhytoMedical.com PhytoMedical Technologies, Inc. ( OTCBB: PYTO ) (FWB: ET6), today announced that the Company will initiate the third phase of Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for ... Trading Markets (press release): Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for ... , CA - Mar 17, 2008 PhytoMedical Technologies, Inc. ( OTCBB: PYTO ), today announced that the Company will initiate the third phase of its drug development program, ... PhytoMedical to Resume Studies for Anti-Cancer Compound NJBIZ: , NJ - Mar 17, 2008 By Shankar P. PhytoMedical Technologies, Inc. ( OTCBB: PYTO ), a pharmaceutical company based in Princeton, today announced the launch of the third phase of a ... PhytoMedical's Latest Anti-Cancer Compounds Kill Human Colon ... Medical News Today (press release): PhytoMedical's Latest Anti-Cancer Compounds Kill Human Colon ... , UK - Mar 5, 2008 PhytoMedical Technologies, Inc. ( OTCBB: PYTO ; Frankfurt Stock Exchange: ET6), together with its wholly owned subsidiaries, is a pharmaceutical co PhytoMedical Continues to Strengthen Research and Development Team ... Business Wire (press release): PhytoMedical Continues to Strengthen Research and Development Team ... , CA - Mar 26, 2007 PhytoMedical Technologies, Inc. ( OTCBB: PYTO ; Frankfurt Stock Exchange: ET6), together with its wholly owned subsidiaries, is a pharmaceutical PhytoMedical Furthers Development of New Class of Compounds for ... Business Wire (press release): PhytoMedical Furthers Development of New Class of Compounds for ... , CA - 1 hour ago PhytoMedical Technologies, Inc. ( OTCBB:PYTO ) (Frankfurt Stock Exchange:ET6), together with its wholly owned subsidiaries, is a pharmaceutical compa PhytoMedical Plans to Expand Compound Pipeline Business Wire (press release): , CA - 15 hours ago PhytoMedical Technologies, Inc. ( OTCBB: PYTO ; Frankfurt Stock Exchange: ET6), together with its wholly owned subsidiaries, is a pharmaceutical company ... PhytoMedical Finalizing Transition of Diabetes Compound Development PharmaLive.com (press release): , PA - 16 hours ago PhytoMedical Technologies, Inc. ( OTCBB: PYTO ; Frankfurt Stock Exchange: ET6), together with its wholly owned subsidiaries, is a pharmaceutical company ... PhytoMedical to Fast Track Development of New Class of Drug for ... Business Wire (press release): (BUSINESS WIRE)--PhytoMedical Technologies, Inc. ( OTCBB : PYTO ) (FWB: ET6) today announced plans to expedite the development of its new class of ... |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign Up | Copyright © 2013 SmallCapWatch, LLC. |
| Never invest based soley on information from this website or our e-mail and IM alerts | |
